Furthermore, a series of studies showed that T regulatory cells decorated with FasL on their surface are effective immunomodulators that alleviate graft-versus-host disease, arrest progression of autoimmune insulitis in non-obese diabetic (NOD) mice, and ameliorate chronic colitis [7,12,13,14,15]. The gene discussed is FASLG; the disease is graft versus host disease.